chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site pain, Joint swelling, Migraine, Mobility decreased, Pain
Clinical narrative: Client received the 2nd COVID vaccine (Moderna Lot # 017C21A expiration 05/23/2021) at 1420. Client reported to EMT that she was feeling nauseas and had a headache ?a 7 out of a 10? at 1441. PHN responded to assess the patient at 1442. Patient was alert and oriented x3 and speaking clearly. EMT offered the patient water which she took and drank. Client stated that all she had to eat today was some crackers. Vital signs were taken at 1441 (Heart rate 84, O2 99%, Blood pressure 132/108). Client denied shortness of breath or vision changes. Vital signs taken at 1457 (O2 98% Heartrate 77 Blood pressure 132/106). When asked how she was feeling at 1459 she said ?so-so, the nausea comes and goes but the headache is the same.? At 1459 client refused EMS and called her husband to come pick her up and to bring her food. Client refused Benadryl. Vital signs taken at 1505 (heart rate 78 O2 98% blood pressure 134/108). At 1511 client stated that her headache is ?still steady.? Vital signs taken at 1511 (blood pressure 128/106). Client advised to follow up with primary care provider or emergency services she said, ?I?ll think about it.? PHN reiterated that it is very important for her to seek emergency services if her symptoms worsen, or new life-threatening symptoms appear. Client had similar symptoms after receiving her first dose of Moderna on 01/07/2021. Her case was brought up through the medical team and she was approved for the second dose of Moderna with a 30-minute observation period. After receiving her vaccine, the client disclosed that she was hospitalized 03/2021 for 10 days, which was not previously disclosed to PHN. She was hospitalized for sepsis, C.diff and a urinary track infection. She said that she has had difficulty eating since the hospitalization and has only been eating ?crackers, broth, and sometimes fresh vegetables.? Client stated that she is currently not taking any medications. She also stated that she is allergic to Naprosyn, Darvocet, and Darvon and they cause severe swelling in her hands. Client advised to get rest, eat, hydrate, and follow up with her primary care provider. Client left the facility at 1538 with her husband unassisted with a steady gait.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Client received the 2nd COVID vaccine (Moderna Lot # 017C21A expiration 05/23/2021) at 1420. Client reported to EMT that she was feeling nauseas and had a headache ?a 7 out of a 10? at 1441. PHN responded to assess the patient at 1442. Patient was alert and oriented x3 and speaking clearly. EMT offered the patient water which she took and drank. Client stated that all she had to eat today was some crackers. Vital signs were taken at 1441 (Heart rate 84, O2 99%, Blood pressure 132/108). Client denied shortness of breath or vision changes. Vital signs taken at 1457 (O2 98% Heartrate 77 Blood pressure 132/106). When asked how she was feeling at 1459 she said ?so-so, the nausea comes and goes but the headache is the same.? At 1459 client refused EMS and called her husband to come pick her up and to bring her food. Client refused Benadryl. Vital signs taken at 1505 (heart rate 78 O2 98% blood pressure 134/108). At 1511 client stated that her headache is ?still steady.? Vital signs taken at 1511 (blood pressure 128/106). Client advised to follow up with primary care provider or emergency services she said, ?I?ll think about it.? PHN reiterated that it is very important for her to seek emergency services if her symptoms worsen, or new life-threatening symptoms appear. Client had similar symptoms after receiving her first dose of Moderna on 01/07/2021. Her case was brought up through the medical team and she was approved for the second dose of Moderna with a 30-minute observation period. After receiving her vaccine, the client disclosed that she was hospitalized 03/2021 for 10 days, which was not previously disclosed to PHN. She was hospitalized for sepsis, C.diff and a urinary track infection. She said that she has had difficulty eating since the hospitalization and has only been eating ?crackers, broth, and sometimes fresh vegetables.? Client stated that she is currently not taking any medications. She also stated that she is allergic to Naprosyn, Darvocet, and Darvon and they cause severe swelling in her hands. Client advised to get rest, eat, hydrate, and follow up with her primary care provider. Client left the facility at 1538 with her husband unassisted with a steady gait.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Malaise, Nausea
Clinical narrative: Client received the 2nd COVID vaccine (Moderna Lot # 017C21A expiration 05/23/2021) at 1420. Client reported to EMT that she was feeling nauseas and had a headache ?a 7 out of a 10? at 1441. PHN responded to assess the patient at 1442. Patient was alert and oriented x3 and speaking clearly. EMT offered the patient water which she took and drank. Client stated that all she had to eat today was some crackers. Vital signs were taken at 1441 (Heart rate 84, O2 99%, Blood pressure 132/108). Client denied shortness of breath or vision changes. Vital signs taken at 1457 (O2 98% Heartrate 77 Blood pressure 132/106). When asked how she was feeling at 1459 she said ?so-so, the nausea comes and goes but the headache is the same.? At 1459 client refused EMS and called her husband to come pick her up and to bring her food. Client refused Benadryl. Vital signs taken at 1505 (heart rate 78 O2 98% blood pressure 134/108). At 1511 client stated that her headache is ?still steady.? Vital signs taken at 1511 (blood pressure 128/106). Client advised to follow up with primary care provider or emergency services she said, ?I?ll think about it.? PHN reiterated that it is very important for her to seek emergency services if her symptoms worsen, or new life-threatening symptoms appear. Client had similar symptoms after receiving her first dose of Moderna on 01/07/2021. Her case was brought up through the medical team and she was approved for the second dose of Moderna with a 30-minute observation period. After receiving her vaccine, the client disclosed that she was hospitalized 03/2021 for 10 days, which was not previously disclosed to PHN. She was hospitalized for sepsis, C.diff and a urinary track infection. She said that she has had difficulty eating since the hospitalization and has only been eating ?crackers, broth, and sometimes fresh vegetables.? Client stated that she is currently not taking any medications. She also stated that she is allergic to Naprosyn, Darvocet, and Darvon and they cause severe swelling in her hands. Client advised to get rest, eat, hydrate, and follow up with her primary care provider. Client left the facility at 1538 with her husband unassisted with a steady gait.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site abscess, Myalgia, Nausea
Clinical narrative: Muscular soreness on whole body; injection site soreness; headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number EL3249) via unspecified route of administration in left arm on 27Jan2021 at 08:30 AM as single dose for COVID-19 immunization. Medical history included COVID-19 (prior to vaccination, the patient was diagnosed with COVID-19). Patient was not pregnant. Concomitant medication included escitalopram oxalate (LEXAPRO) and esomeprazole magnesium (NEXIUM) (within 2 weeks of vaccination). No other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021 at 12:00 AM, the patient experienced muscular soreness on whole body, injection site soreness, headache, nausea. Patient did not receive treatment for an event. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Nausea, Vaccination site pain
Clinical narrative: Muscular soreness on whole body; injection site soreness; headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 38-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number EL3249) via unspecified route of administration in left arm on 27Jan2021 at 08:30 AM as single dose for COVID-19 immunization. Medical history included COVID-19 (prior to vaccination, the patient was diagnosed with COVID-19). Patient was not pregnant. Concomitant medication included escitalopram oxalate (LEXAPRO) and esomeprazole magnesium (NEXIUM) (within 2 weeks of vaccination). No other vaccines within 4 weeks prior to the COVID vaccine. On 28Jan2021 at 12:00 AM, the patient experienced muscular soreness on whole body, injection site soreness, headache, nausea. Patient did not receive treatment for an event. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Swelling face, Tachycardia
Clinical narrative: Extreme Dizziness immediately; Face Swelling; Rapid heartbeat; Joint Pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9262) (age at vaccination was 55 Years and non-pregnant at the time of vaccination) via unspecified route of administration on 26Jan2021 14:00 in left arm as single dose for COVID-19 immunization. The patient's medical history included Sjogrens Syndrom and high Blood Pressure. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. Concomitant medication (list of any other medications the patient received within 2 weeks of vaccination) included Losartin 100mg, HCT 25mg. On 26Jan2021, the patient experienced extreme dizziness immediately, face swelling, rapid heartbeat, joint pain. It was unknown whether the patient received any treatment for the events. These events resulted in emergency room/department or urgent care. The outcome of the events was reported as not recovered.  Follow-up attempts are completed. No further information was expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Dizziness, Heart rate, Heart rate increased, Swelling face
Clinical narrative: Extreme Dizziness immediately; Face Swelling; Rapid heartbeat; Joint Pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 55-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9262) (age at vaccination was 55 Years and non-pregnant at the time of vaccination) via unspecified route of administration on 26Jan2021 14:00 in left arm as single dose for COVID-19 immunization. The patient's medical history included Sjogrens Syndrom and high Blood Pressure. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. Concomitant medication (list of any other medications the patient received within 2 weeks of vaccination) included Losartin 100mg, HCT 25mg. On 26Jan2021, the patient experienced extreme dizziness immediately, face swelling, rapid heartbeat, joint pain. It was unknown whether the patient received any treatment for the events. These events resulted in emergency room/department or urgent care. The outcome of the events was reported as not recovered.  Follow-up attempts are completed. No further information was expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Injection site pain, Myalgia, Nausea, Neck pain
Clinical narrative: muscle soreness in my arms and legs; felt a tingle sensation in my fingers on my left hand/22Jan, the slight tingle sensation in both hands and feet on my left and right side; arm hurt at the injection site/left arm hurt where received the shot; headache/continued and had a very bad headache; my neck hurt; felt a little nauseous; This is a spontaneous report from a contactable consumer(patient).  A 36-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249 and Expiration date was not reported), via unknown route of administration in left arm, on 20Jan2021 at 13:15, as single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was not the patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. The patient medical history was not reported. The concomitant medications included the patient received within 2 weeks of vaccination are Vitamin D, Prenatal Vitamin for prior breastfeeding. On 20Jan2021 at 13:15, same day of vaccination, after patient got the vaccine and went into the observation tent and felt a tingle sensation in fingers on left hand and arm hurt at the injection site. After returned home, the rest of the day/night, left arm hurt where received the shot, had a headache, neck hurt, and felt a little nauseous. The next day, 21Jan, felt a slight tingle sensation in both hands and feet on left and right side. On 22Jan, the slight tingle sensation in both hands and feet on left and right side continued and had a very bad headache. The slight tingle sensation has continued with some muscle soreness in arms and legs. The tingle sensation is intermittent throughout the day in fingers and toes and had no numbness. It is a slight minor tingle sensation. Patient messaged doctor on 25Jan and was advised to monitor it and contact back if it continued. The muscle soreness has subsided present day (30Jan), but the tingling remains in hands and feet. The treatment received for the events was no. The outcome of the events neck pain, headache, vaccination site pain, paraesthesia were reported as not recovered, the event muscle soreness was recovered on 30Jan2021.  Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: muscle soreness in my arms and legs; felt a tingle sensation in my fingers on my left hand/22Jan, the slight tingle sensation in both hands and feet on my left and right side; arm hurt at the injection site/left arm hurt where received the shot; headache/continued and had a very bad headache; my neck hurt; felt a little nauseous; This is a spontaneous report from a contactable consumer(patient).  A 36-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249 and Expiration date was not reported), via unknown route of administration in left arm, on 20Jan2021 at 13:15, as single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was not the patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. The patient medical history was not reported. The concomitant medications included the patient received within 2 weeks of vaccination are Vitamin D, Prenatal Vitamin for prior breastfeeding. On 20Jan2021 at 13:15, same day of vaccination, after patient got the vaccine and went into the observation tent and felt a tingle sensation in fingers on left hand and arm hurt at the injection site. After returned home, the rest of the day/night, left arm hurt where received the shot, had a headache, neck hurt, and felt a little nauseous. The next day, 21Jan, felt a slight tingle sensation in both hands and feet on left and right side. On 22Jan, the slight tingle sensation in both hands and feet on left and right side continued and had a very bad headache. The slight tingle sensation has continued with some muscle soreness in arms and legs. The tingle sensation is intermittent throughout the day in fingers and toes and had no numbness. It is a slight minor tingle sensation. Patient messaged doctor on 25Jan and was advised to monitor it and contact back if it continued. The muscle soreness has subsided present day (30Jan), but the tingling remains in hands and feet. The treatment received for the events was no. The outcome of the events neck pain, headache, vaccination site pain, paraesthesia were reported as not recovered, the event muscle soreness was recovered on 30Jan2021.  Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Myalgia, Nausea, Neck pain, Paraesthesia
Clinical narrative: muscle soreness in my arms and legs; felt a tingle sensation in my fingers on my left hand/22Jan, the slight tingle sensation in both hands and feet on my left and right side; arm hurt at the injection site/left arm hurt where received the shot; headache/continued and had a very bad headache; my neck hurt; felt a little nauseous; This is a spontaneous report from a contactable consumer(patient).  A 36-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249 and Expiration date was not reported), via unknown route of administration in left arm, on 20Jan2021 at 13:15, as single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was not the patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. The patient medical history was not reported. The concomitant medications included the patient received within 2 weeks of vaccination are Vitamin D, Prenatal Vitamin for prior breastfeeding. On 20Jan2021 at 13:15, same day of vaccination, after patient got the vaccine and went into the observation tent and felt a tingle sensation in fingers on left hand and arm hurt at the injection site. After returned home, the rest of the day/night, left arm hurt where received the shot, had a headache, neck hurt, and felt a little nauseous. The next day, 21Jan, felt a slight tingle sensation in both hands and feet on left and right side. On 22Jan, the slight tingle sensation in both hands and feet on left and right side continued and had a very bad headache. The slight tingle sensation has continued with some muscle soreness in arms and legs. The tingle sensation is intermittent throughout the day in fingers and toes and had no numbness. It is a slight minor tingle sensation. Patient messaged doctor on 25Jan and was advised to monitor it and contact back if it continued. The muscle soreness has subsided present day (30Jan), but the tingling remains in hands and feet. The treatment received for the events was no. The outcome of the events neck pain, headache, vaccination site pain, paraesthesia were reported as not recovered, the event muscle soreness was recovered on 30Jan2021.  Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: muscle soreness in my arms and legs; felt a tingle sensation in my fingers on my left hand/22Jan, the slight tingle sensation in both hands and feet on my left and right side; arm hurt at the injection site/left arm hurt where received the shot; headache/continued and had a very bad headache; my neck hurt; felt a little nauseous; This is a spontaneous report from a contactable consumer(patient).  A 36-year-old female received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL3249 and Expiration date was not reported), via unknown route of administration in left arm, on 20Jan2021 at 13:15, as single dose for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was not the patient diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had no known allergies. The patient medical history was not reported. The concomitant medications included the patient received within 2 weeks of vaccination are Vitamin D, Prenatal Vitamin for prior breastfeeding. On 20Jan2021 at 13:15, same day of vaccination, after patient got the vaccine and went into the observation tent and felt a tingle sensation in fingers on left hand and arm hurt at the injection site. After returned home, the rest of the day/night, left arm hurt where received the shot, had a headache, neck hurt, and felt a little nauseous. The next day, 21Jan, felt a slight tingle sensation in both hands and feet on left and right side. On 22Jan, the slight tingle sensation in both hands and feet on left and right side continued and had a very bad headache. The slight tingle sensation has continued with some muscle soreness in arms and legs. The tingle sensation is intermittent throughout the day in fingers and toes and had no numbness. It is a slight minor tingle sensation. Patient messaged doctor on 25Jan and was advised to monitor it and contact back if it continued. The muscle soreness has subsided present day (30Jan), but the tingling remains in hands and feet. The treatment received for the events was no. The outcome of the events neck pain, headache, vaccination site pain, paraesthesia were reported as not recovered, the event muscle soreness was recovered on 30Jan2021.  Follow-up attempts are completed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Headache, Oropharyngeal pain, Pain
Clinical narrative: Fever; headache; chills; minimal coughing; sore throat; This is a spontaneous report received from a contactable consumer reported for herself. A 29-year-old-non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number:Unknown) via an unspecified route of administration in the left arm on 29Jan2021 at 14:30 (at the age of 29-year-old) as a single dose for COVID-19 immunization in clinic and also received other vaccine (unspecified) on the same day in left arm for an unspecified indication. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and minerals nos, vitamins nos (PRENATAL VITAMINS) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Jan2021 at 19:00, the patient experienced fever, headache, chills, minimal coughing/sore throat which lasting longer than 48 hours. Patient did not received any treatment for the events. The outcome of events was not recovered.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; headache; chills; minimal coughing; sore throat; This is a spontaneous report received from a contactable consumer reported for herself. A 29-year-old-non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number:Unknown) via an unspecified route of administration in the left arm on 29Jan2021 at 14:30 (at the age of 29-year-old) as a single dose for COVID-19 immunization in clinic and also received other vaccine (unspecified) on the same day in left arm for an unspecified indication. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and minerals nos, vitamins nos (PRENATAL VITAMINS) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Jan2021 at 19:00, the patient experienced fever, headache, chills, minimal coughing/sore throat which lasting longer than 48 hours. Patient did not received any treatment for the events. The outcome of events was not recovered.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever; headache; chills; minimal coughing; sore throat; This is a spontaneous report received from a contactable consumer reported for herself. A 29-year-old-non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number:Unknown) via an unspecified route of administration in the left arm on 29Jan2021 at 14:30 (at the age of 29-year-old) as a single dose for COVID-19 immunization in clinic and also received other vaccine (unspecified) on the same day in left arm for an unspecified indication. The patient had no medical history. Concomitant medications included ascorbic acid (VITAMIN C) and minerals nos, vitamins nos (PRENATAL VITAMINS) within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Jan2021 at 19:00, the patient experienced fever, headache, chills, minimal coughing/sore throat which lasting longer than 48 hours. Patient did not received any treatment for the events. The outcome of events was not recovered.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Hypoaesthesia, Pain, Paraesthesia
Clinical narrative: Electrical/jolt feeling on chest (both sides)/Also occurring on right arm, down arm and bask side down right side of back; very uncomfortable; hand/arm feels swollen and tight; This is a spontaneous report from a contactable other HCP (patient). A 32-year-old non-pregnant female reported for herself who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, Batch/lot number: En5318), via an unspecified route of administration in right arm on 29Jan2021 at 09:30 (at 32-years age) as single dose for covid-19 immunization. The patient was diagnosed with COVID-19 prior to vaccination. The patient did not have any allergy to medications, food, or other products. The patient's concomitant medications that patient received within 2 weeks of vaccination included vitamin d nos (VITAMIN D NOS); vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) and zinc (ZINC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Jan2021 at 19:00, the patient experienced electrical/jolt feeling on chest (both sides). Also occurring on right arm, down arm and bask side down right side of back. Starts as a jolt and not feels numb (pins and needles). It didn't hurt but was very uncomfortable and hand/arm felt swollen and tight. The patient did not receive any treatment for the events. Since the vaccination, the patient was not tested for COVID-19. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Discomfort, Electric shock sensation, Peripheral swelling
Clinical narrative: Electrical/jolt feeling on chest (both sides)/Also occurring on right arm, down arm and bask side down right side of back; very uncomfortable; hand/arm feels swollen and tight; This is a spontaneous report from a contactable other HCP (patient). A 32-year-old non-pregnant female reported for herself who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), Solution for injection, Batch/lot number: En5318), via an unspecified route of administration in right arm on 29Jan2021 at 09:30 (at 32-years age) as single dose for covid-19 immunization. The patient was diagnosed with COVID-19 prior to vaccination. The patient did not have any allergy to medications, food, or other products. The patient's concomitant medications that patient received within 2 weeks of vaccination included vitamin d nos (VITAMIN D NOS); vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) and zinc (ZINC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Jan2021 at 19:00, the patient experienced electrical/jolt feeling on chest (both sides). Also occurring on right arm, down arm and bask side down right side of back. Starts as a jolt and not feels numb (pins and needles). It didn't hurt but was very uncomfortable and hand/arm felt swollen and tight. The patient did not receive any treatment for the events. Since the vaccination, the patient was not tested for COVID-19. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Erythema, Rash
Clinical narrative: Rash; redness; This is a spontaneous report from a contactable nurse reporting for himself. This 22-year-old male patient received on 09Feb2021 04:00 PM BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm as a single dose at the age of 22-years for COVID-19 immunization. Medical history and concomitant medication were not reported. No other vaccinations have been administered within 4 weeks before. On 09Feb2021 09:00 PM, the patient had rash and redness. No treatment was provided. Outcome was recovering. Information on the batch number has been requested.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient) reported that a 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265; expiration date: 31May2021), intramuscular, administered in arm right on 28Jan2021 16:00 (at the age of 77-years-old) as 1st dose, single for covid-19 immunisation. The vaccine was administered at the hospital. The patient medical history included hysterectomy from 07Dec2020. There were no concomitant medications. Ten days later on 07Feb2021, the patient had onset of shingles. She was prescribed medication for shingles, and finished her last pill of that medication on 20Feb2021. She was scheduled to get her second dose of Pfizer COVID-19 Vaccine, and wanted to know if it would be ok to get that second dose relative to this event. She was scheduled to get her second covid-19 vaccine dose on the 11Mar2021. The clinical course of patient's shingles was described as all the bumps that she did get have dried except for one little spot; it all was on left side of head and face and it seems to be pretty much gone. One little sensitive spot remains where it first began back on the crown of her head on the left side. The itching is gone. The areas on the scalp and forehead have dried up, although there is still a little bumpiness but no itching or burning or anything like that. It's been an ordeal. She does feel like her doctor got her treated quickly and the medication was effective; the shingles was not as severe as some shingles cases can be. The event 'shingles' resulted in physician office visit. The patient underwent lab tests and procedures which included blood test: everything looked good on 22Feb2021. The outcome of the event was recovering.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient) reported that a 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265; expiration date: 31May2021), intramuscular, administered in arm right on 28Jan2021 16:00 (at the age of 77-years-old) as 1st dose, single for covid-19 immunisation. The vaccine was administered at the hospital. The patient medical history included hysterectomy from 07Dec2020. There were no concomitant medications. Ten days later on 07Feb2021, the patient had onset of shingles. She was prescribed medication for shingles, and finished her last pill of that medication on 20Feb2021. She was scheduled to get her second dose of Pfizer COVID-19 Vaccine, and wanted to know if it would be ok to get that second dose relative to this event. She was scheduled to get her second covid-19 vaccine dose on the 11Mar2021. The clinical course of patient's shingles was described as all the bumps that she did get have dried except for one little spot; it all was on left side of head and face and it seems to be pretty much gone. One little sensitive spot remains where it first began back on the crown of her head on the left side. The itching is gone. The areas on the scalp and forehead have dried up, although there is still a little bumpiness but no itching or burning or anything like that. It's been an ordeal. She does feel like her doctor got her treated quickly and the medication was effective; the shingles was not as severe as some shingles cases can be. The event 'shingles' resulted in physician office visit. The patient underwent lab tests and procedures which included blood test: everything looked good on 22Feb2021. The outcome of the event was recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Erythema, Fatigue, Myalgia
Clinical narrative: heaviness/burning in chest; heaviness/burning in chest; tingling/stabbing pain all over skin; red lesion on lower back; Shingles; light-headedness; fatigue; 101 fever; muscle aches/pain; joint pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EK4176), via an unspecified route of administration, administered in left arm on 09Feb2021 10:00 as 2nd dose, single for COVID-19 immunisation. Medical history included osteoarthritis back/hip treated with steroid injections, bilateral knee replacements. Concomitant medications included lisinopril, hydrochlorothiazide, paracetamol (TYLENOL), and montelukast. The patient previously took levofloxacin (LEVAQUIN) and experienced known allergies. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EJ1686) administered in the left arm on 19Jan2021 at 10:30 AM for COVID-19 immunization. Vaccine facility type was hospital. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 09Feb2021 at 21:00, the patient experienced heaviness/burning in chest, tingling/stabbing pain all over skin, red lesion on lower back, the worst shingles attack ever had and have had shingrix vaccine. The patient also experienced light-headedness, fatigue, 101 fever, muscle aches/pain, and joint pain. No treatment was received for all events except for shingles. The patient underwent lab test and result and included body temperature: 101 on an unspecified date. The outcome of the events were recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain of skin, Paraesthesia, Pyrexia, Skin burning sensation
Clinical narrative: heaviness/burning in chest; heaviness/burning in chest; tingling/stabbing pain all over skin; red lesion on lower back; Shingles; light-headedness; fatigue; 101 fever; muscle aches/pain; joint pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EK4176), via an unspecified route of administration, administered in left arm on 09Feb2021 10:00 as 2nd dose, single for COVID-19 immunisation. Medical history included osteoarthritis back/hip treated with steroid injections, bilateral knee replacements. Concomitant medications included lisinopril, hydrochlorothiazide, paracetamol (TYLENOL), and montelukast. The patient previously took levofloxacin (LEVAQUIN) and experienced known allergies. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EJ1686) administered in the left arm on 19Jan2021 at 10:30 AM for COVID-19 immunization. Vaccine facility type was hospital. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 09Feb2021 at 21:00, the patient experienced heaviness/burning in chest, tingling/stabbing pain all over skin, red lesion on lower back, the worst shingles attack ever had and have had shingrix vaccine. The patient also experienced light-headedness, fatigue, 101 fever, muscle aches/pain, and joint pain. No treatment was received for all events except for shingles. The patient underwent lab test and result and included body temperature: 101 on an unspecified date. The outcome of the events were recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Skin lesion
Clinical narrative: heaviness/burning in chest; heaviness/burning in chest; tingling/stabbing pain all over skin; red lesion on lower back; Shingles; light-headedness; fatigue; 101 fever; muscle aches/pain; joint pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EK4176), via an unspecified route of administration, administered in left arm on 09Feb2021 10:00 as 2nd dose, single for COVID-19 immunisation. Medical history included osteoarthritis back/hip treated with steroid injections, bilateral knee replacements. Concomitant medications included lisinopril, hydrochlorothiazide, paracetamol (TYLENOL), and montelukast. The patient previously took levofloxacin (LEVAQUIN) and experienced known allergies. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EJ1686) administered in the left arm on 19Jan2021 at 10:30 AM for COVID-19 immunization. Vaccine facility type was hospital. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 09Feb2021 at 21:00, the patient experienced heaviness/burning in chest, tingling/stabbing pain all over skin, red lesion on lower back, the worst shingles attack ever had and have had shingrix vaccine. The patient also experienced light-headedness, fatigue, 101 fever, muscle aches/pain, and joint pain. No treatment was received for all events except for shingles. The patient underwent lab test and result and included body temperature: 101 on an unspecified date. The outcome of the events were recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Body temperature, Chest discomfort, Chest pain, Dizziness
Clinical narrative: heaviness/burning in chest; heaviness/burning in chest; tingling/stabbing pain all over skin; red lesion on lower back; Shingles; light-headedness; fatigue; 101 fever; muscle aches/pain; joint pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EK4176), via an unspecified route of administration, administered in left arm on 09Feb2021 10:00 as 2nd dose, single for COVID-19 immunisation. Medical history included osteoarthritis back/hip treated with steroid injections, bilateral knee replacements. Concomitant medications included lisinopril, hydrochlorothiazide, paracetamol (TYLENOL), and montelukast. The patient previously took levofloxacin (LEVAQUIN) and experienced known allergies. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EJ1686) administered in the left arm on 19Jan2021 at 10:30 AM for COVID-19 immunization. Vaccine facility type was hospital. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 09Feb2021 at 21:00, the patient experienced heaviness/burning in chest, tingling/stabbing pain all over skin, red lesion on lower back, the worst shingles attack ever had and have had shingrix vaccine. The patient also experienced light-headedness, fatigue, 101 fever, muscle aches/pain, and joint pain. No treatment was received for all events except for shingles. The patient underwent lab test and result and included body temperature: 101 on an unspecified date. The outcome of the events were recovering.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysaesthesia, Fatigue, Herpes zoster, Myalgia, Pyrexia
Clinical narrative: heaviness/burning in chest; heaviness/burning in chest; tingling/stabbing pain all over skin; red lesion on lower back; Shingles; light-headedness; fatigue; 101 fever; muscle aches/pain; joint pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EK4176), via an unspecified route of administration, administered in left arm on 09Feb2021 10:00 as 2nd dose, single for COVID-19 immunisation. Medical history included osteoarthritis back/hip treated with steroid injections, bilateral knee replacements. Concomitant medications included lisinopril, hydrochlorothiazide, paracetamol (TYLENOL), and montelukast. The patient previously took levofloxacin (LEVAQUIN) and experienced known allergies. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID019 VACCINE; Lot Number: EJ1686) administered in the left arm on 19Jan2021 at 10:30 AM for COVID-19 immunization. Vaccine facility type was hospital. The patient had no other vaccine in four weeks. The patient had no COVID prior to vaccination. The patient was not tested for COVID post vaccination. On 09Feb2021 at 21:00, the patient experienced heaviness/burning in chest, tingling/stabbing pain all over skin, red lesion on lower back, the worst shingles attack ever had and have had shingrix vaccine. The patient also experienced light-headedness, fatigue, 101 fever, muscle aches/pain, and joint pain. No treatment was received for all events except for shingles. The patient underwent lab test and result and included body temperature: 101 on an unspecified date. The outcome of the events were recovering.
Age: 38.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Rhabdomyolysis
Clinical narrative: ID: 37yo F previously healthy radiology tech developed progressive muscle weakness and SOB after the 2nd dose of COVID vaccine. HPI: Patient was previously healthy and physically active prior to COVID vaccines. No prior COVId infection. No prior MSK pain, arthritis, arthralgias. No prior rash. No dry eye / dry mouth. She received the first dose of Pfizer COVID vaccine at the end of Dec 2020 and experienced achiness and fatigue that resolved after a few days. For the first time, her fingertips and toes also started turning white, numb and painful when cold. She received a second dose on Jan 12, 2021 and immediately experienced heart palpitations while at the vaccination site, and later heartburn and vomiting when she went back to work. The following week, she developed sore throat for 2 days, took leftover amoxicillin at home. All of these symptoms resolved after a few days. She However, she developed gradual SOB, muscle ache and fatigue, initially mild but worsened over a few weeks. She noticed feeling out of breath, arms giving out, legs burning when pushing stretchers to patient rooms. One morning while she was getting up for work, she couldn't lift up leg, but had to pick up her legs so she get into her car. She also had to pick up her leg with arms to get into shower. "It felt like waking up every morning having run a marathon." On 2/13 she went to ER, got admitted for CK 30,000 for rhabdo treatment for 4 days. She denied having done extreme sports or increased physical activity that might have caused rhabdo. On discharge home, she could barely walk and continued SOB. She also developed additional rash on left arm, chest and shoulders. A physician ordered lab work and found her CK to be 50K, so she was admitted again on March 6 for 8 days, discharged on 3/14/2021. Denies fever since COVID vaccination.
Age: 38.0
Sex: F
Vaccine: UNK, COVID19
Symptoms: Biopsy, Blood creatine phosphokinase increased, Burning sensation, Dyspepsia, Dyspnoea
Clinical narrative: ID: 37yo F previously healthy radiology tech developed progressive muscle weakness and SOB after the 2nd dose of COVID vaccine. HPI: Patient was previously healthy and physically active prior to COVID vaccines. No prior COVId infection. No prior MSK pain, arthritis, arthralgias. No prior rash. No dry eye / dry mouth. She received the first dose of Pfizer COVID vaccine at the end of Dec 2020 and experienced achiness and fatigue that resolved after a few days. For the first time, her fingertips and toes also started turning white, numb and painful when cold. She received a second dose on Jan 12, 2021 and immediately experienced heart palpitations while at the vaccination site, and later heartburn and vomiting when she went back to work. The following week, she developed sore throat for 2 days, took leftover amoxicillin at home. All of these symptoms resolved after a few days. She However, she developed gradual SOB, muscle ache and fatigue, initially mild but worsened over a few weeks. She noticed feeling out of breath, arms giving out, legs burning when pushing stretchers to patient rooms. One morning while she was getting up for work, she couldn't lift up leg, but had to pick up her legs so she get into her car. She also had to pick up her leg with arms to get into shower. "It felt like waking up every morning having run a marathon." On 2/13 she went to ER, got admitted for CK 30,000 for rhabdo treatment for 4 days. She denied having done extreme sports or increased physical activity that might have caused rhabdo. On discharge home, she could barely walk and continued SOB. She also developed additional rash on left arm, chest and shoulders. A physician ordered lab work and found her CK to be 50K, so she was admitted again on March 6 for 8 days, discharged on 3/14/2021. Denies fever since COVID vaccination.